Celularity (CELU)
(Delayed Data from NSDQ)
$3.38 USD
+0.17 (5.30%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.39 +0.01 (0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Celularity, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 14 | 37 | 0 | 1 |
Receivables | NA | 7 | 5 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 5 | 10 | 0 | 0 |
Other Current Assets | NA | 7 | 7 | 0 | 0 |
Total Current Assets | NA | 34 | 59 | 0 | 1 |
Net Property & Equipment | NA | 76 | 91 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 292 | 291 |
Other Non-Current Assets | NA | 23 | 3 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 241 | 246 | 0 | 0 |
Deposits & Other Assets | NA | 15 | 15 | 0 | 0 |
Total Assets | NA | 401 | 414 | 292 | 292 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 6 | 9 | 3 | 0 |
Current Portion Long-Term Debt | NA | 38 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 3 | 0 | 0 |
Accrued Expenses | NA | 16 | 12 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 2 | 2 | 0 | 0 |
Total Current Liabilities | NA | 62 | 26 | 3 | 0 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 2 | 2 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 28 | 0 | 0 |
Other Non-Current Liabilities | NA | 110 | 259 | 284 | 286 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 202 | 315 | 287 | 287 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 844 | 763 | 5 | 2 |
Retained Earnings | NA | -646 | -664 | 0 | 3 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 199 | 99 | 5 | 5 |
Total Liabilities & Shareholder's Equity | NA | 401 | 414 | 292 | 292 |
Total Common Equity | 0 | 199 | 99 | 5 | 5 |
Shares Outstanding | 19.30 | 14.80 | 12.40 | 3.50 | 3.50 |
Book Value Per Share | 0.00 | 13.44 | 8.02 | 1.43 | 1.43 |
Fiscal Year End for Celularity, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 0 | 3 | 9 |
Receivables | NA | NA | 6 | 5 | 5 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 5 | 6 | 5 |
Other Current Assets | NA | NA | 5 | 4 | 6 |
Total Current Assets | NA | NA | 17 | 18 | 25 |
Net Property & Equipment | NA | NA | 71 | 73 | 74 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 25 | 25 | 25 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 19 | 102 | 211 |
Deposits & Other Assets | NA | NA | 15 | 15 | 15 |
Total Assets | NA | NA | 157 | 246 | 362 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | 0 |
Accounts Payable | NA | NA | 13 | 12 | 9 |
Current Portion Long-Term Debt | NA | NA | 35 | 17 | 31 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | NA | 34 | 33 | 25 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 2 | 2 | 2 |
Total Current Liabilities | NA | NA | 85 | 65 | 66 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 3 | 2 | 2 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 0 | 17 | 5 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 13 | 15 | 105 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 127 | 128 | 207 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 0 | 0 | 0 |
Capital Surplus | NA | NA | 879 | 874 | 862 |
Retained Earnings | NA | NA | -851 | -757 | -710 |
Other Equity | NA | NA | 2 | 2 | 3 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | NA | 30 | 119 | 156 |
Total Liabilities & Shareholder's Equity | NA | NA | 157 | 246 | 362 |
Total Common Equity | 0 | 0 | 30 | 119 | 156 |
Shares Outstanding | 19.30 | 19.30 | 19.30 | 18.00 | 16.50 |
Book Value Per Share | 0.00 | 0.00 | 1.57 | 6.58 | 9.43 |